rs267608436
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP5BS2
This summary comes from the ClinGen Evidence Repository: The p.Arg65Gln variant in CDKL5 is present in 2 female and 1 male individuals in gnomAD (0.002%) (not sufficient to meet BS1 criteria). The p.Arg65Gln variant is observed in at least 2 unaffected individuals (internal database) (BS2). The p.Arg65Gln variant is found in 2 patients with an alternate molecular basis of disease (internal database) (BP5). In summary, the p.Arg65Gln variant in CDKL5 is classified as likely benign based on the ACMG/AMP criteria (BS2, BP5). LINK:https://erepo.genome.network/evrepo/ui/classification/CA170462/MONDO:0100039/034
Frequency
Consequence
NM_001323289.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDKL5 | NM_001323289.2 | c.194G>A | p.Arg65Gln | missense_variant | 5/18 | ENST00000623535.2 | NP_001310218.1 | |
CDKL5 | NM_001037343.2 | c.194G>A | p.Arg65Gln | missense_variant | 6/22 | NP_001032420.1 | ||
CDKL5 | NM_003159.3 | c.194G>A | p.Arg65Gln | missense_variant | 5/21 | NP_003150.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CDKL5 | ENST00000623535.2 | c.194G>A | p.Arg65Gln | missense_variant | 5/18 | 1 | NM_001323289.2 | ENSP00000485244.1 |
Frequencies
GnomAD3 genomes AF: 0.0000179 AC: 2AN: 111779Hom.: 0 Cov.: 23 AF XY: 0.0000294 AC XY: 1AN XY: 34005
GnomAD3 exomes AF: 0.0000164 AC: 3AN: 182997Hom.: 0 AF XY: 0.0000148 AC XY: 1AN XY: 67635
GnomAD4 exome AF: 0.0000165 AC: 18AN: 1093207Hom.: 0 Cov.: 28 AF XY: 0.0000223 AC XY: 8AN XY: 358913
GnomAD4 genome AF: 0.0000179 AC: 2AN: 111779Hom.: 0 Cov.: 23 AF XY: 0.0000294 AC XY: 1AN XY: 34005
ClinVar
Submissions by phenotype
CDKL5 disorder Benign:2
Likely benign, reviewed by expert panel | curation | ClinGen Rett and Angelman-like Disorders Variant Curation Expert Panel | Aug 23, 2023 | The p.Arg65Gln variant in CDKL5 is present in 2 female and 1 male individuals in gnomAD (0.002%) (not sufficient to meet BS1 criteria). The p.Arg65Gln variant is observed in at least 2 unaffected individuals (internal database) (BS2). The p.Arg65Gln variant is found in 2 patients with an alternate molecular basis of disease (internal database) (BP5). In summary, the p.Arg65Gln variant in CDKL5 is classified as likely benign based on the ACMG/AMP criteria (BS2, BP5). - |
Benign, criteria provided, single submitter | curation | Centre for Population Genomics, CPG | Jul 02, 2024 | This variant has been collected from RettBASE and curated to current modified ACMG/AMP criteria. Based on the classification scheme defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders Specifications to the ACMG/AMP Variant Interpretation Guidelines VCEP 3.0, this variant is classified as benign. At least the following criteria are met: The allele frequency of this variant in at least one population in population databases (gnomAD , Turkish Variome) is between 0.008% and 0.03% (BS1). The variant is observed in at least 2 individuals with no features of CDKL5 disorder (BS2). PubMed: 17993579 Variation ID: 143789 - |
not specified Benign:1
Benign, no assertion criteria provided | curation | RettBASE | May 09, 2014 | Reported in paper as c.193C>A, but chromatogram shows c.194G>A; found in unaffected male family member; however, In silico prediction: SIFT = deleterious, MutationTaster = disease-causing, PolyPhen2 = probably damaging, AlignGVGD = pathogenic (C35) - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | May 05, 2021 | This variant is associated with the following publications: (PMID: 17993579) - |
CDKL5-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 08, 2021 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Developmental and epileptic encephalopathy, 2;CN128785:Angelman syndrome-like Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 14, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at